1. Home
  2. MOGU vs ITRM Comparison

MOGU vs ITRM Comparison

Compare MOGU & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MOGU Inc.

MOGU

MOGU Inc.

HOLD

Current Price

$2.50

Market Cap

20.4M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

SELL

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MOGU
ITRM
Founded
2011
2015
Country
China
Ireland
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
24.3M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
MOGU
ITRM
Price
$2.50
$0.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
4.1K
51.6M
Earning Date
01-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
$13.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.03
52 Week High
$8.10
$1.42

Technical Indicators

Market Signals
Indicator
MOGU
ITRM
Relative Strength Index (RSI) 55.69 26.10
Support Level $2.47 N/A
Resistance Level $2.56 $0.39
Average True Range (ATR) 0.18 0.02
MACD 0.02 -0.01
Stochastic Oscillator 80.69 3.34

Price Performance

Historical Comparison
MOGU
ITRM

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: